C92.21
✓ Billable
Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
ICD-10-CM · FY2026 · Neoplasms
Code
C92.21
System
ICD-10-CM
Billable
Yes — valid for submission
Effective
FY2026
Chapter
Neoplasms
Source
CMS / CDC NCHS
⚠ Verify before billing. Confirm against the current CMS/NCHS ICD-10-CM files and your payer's rules before claims submission.
Frequently asked questions
What is ICD-10 code C92.21?
ICD-10-CM code C92.21 represents Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission. It is a billable diagnosis code in the Neoplasms chapter, effective October 1, 2025 – September 30, 2026.
Is C92.21 billable?
Yes. C92.21 is a valid billable ICD-10-CM code for insurance claims and clinical documentation.
What chapter is C92.21 in?
C92.21 belongs to the Neoplasms chapter (C00–D49) of ICD-10-CM.
Related codes in the C92 category
C92
Myeloid leukemia
Non-billable
C92.0
Acute myeloblastic leukemia
Non-billable
C92.1
Chronic myeloid leukemia, BCR/ABL-positive
Non-billable
C92.2
Atypical chronic myeloid leukemia, BCR/ABL-negative
Non-billable
C92.3
Myeloid sarcoma
Non-billable
C92.4
Acute promyelocytic leukemia
Non-billable
C92.5
Acute myelomonocytic leukemia
Non-billable
C92.6
Acute myeloid leukemia with 11q23-abnormality
Non-billable
Search all 98,186 ICD-10-CM codes instantly
Search ICDwise →